A single 10 mg vial, reconstituted properly, can supply enough semaglutide for the initial titration phases of a standard protocol

Medications are limited to a 30-day supply due to high cost and to prevent waste Self-administered products are standardly covered under the pharmacy benefit while physician-administered products are covered under the medical benefit We deliver savings on specialty drugs for our clients and member through Primes Specialty Network offering Accredo, our specialty pharmacy partner, has pharmacies across the country that allows drugs to be dispensed from the pharmacy location closest to the patient Contact Us Phone: (972) 666-0578 Email: [email protected] Find What Plans Your Doctor Accepts Find Every Plan In Your Area Calculate Your Subsidy Live Chat Our Agents Apply On Or Off the Exchange Apply in Under 5 Minutes Ryan Kennelly authorized agent for Blue Cross and Blue Shield of Texas Blue Cross and Blue Shield of Texas: A Division of Health Care Service Corporation, a Mutual Legal Reserve Company, an Independent Licensee of the Blue Cross and Blue Shield Association

For patients interested in participating in research , the following resources may be helpful: NIHR Be Part of Research (bepartofresearch.nihr.ac.uk) search for Parkinson's and GLP-1 trials Parkinson's UK (www.parkinsons.org.uk) information on current research and trial opportunities When to contact your GP or specialist : If you have Parkinson's disease and diabetes, and wish to discuss whether a GLP-1 receptor agonist is appropriate for your diabetes management If you experience new or worsening symptoms whilst taking any medication If you are interested in clinical trial participationyour neurologist can advise on suitable studies Seek urgent medical attention if you experience: Severe, persistent abdominal pain (possible pancreatitis) Persistent vomiting or inability to keep fluids down (risk of dehydration) Signs of dehydration (extreme thirst, dark urine, dizziness) Allergic reaction (rash, swelling, difficulty breathing) Patients should never start, stop, or modify medications without medical supervision

In its warning, the FDA said that some users of compounded products ended up needing hospital care due to dosing errors related to confusion over units of measurement, fluctuating product concentrations and the use of multiple-dose vials
Working with a dietitian alongside your therapy is the "secret sauce" to long-term success
Purpose-built for physicians GLP-1 receptor agonists linked to lower mortality, respiratory failure in PAH Key takeaways: A link was found between GLP-1 receptor agonist use in PAH and significant decreases in mortality, respiratory failure, atrial fibrillation and ED visits